Skip to main content
Premium Trial:

Request an Annual Quote

Lenard Boggio and Paul Terry

Genome British Columbia has appointed Lenard Boggio and Paul Terry to its board of directors. Boggio currently serves as an independent director on the boards of several publicly listed companies, and serves as commissioner of the Financial Institutions Commission of British Columbia. Before, he served as president of the Institute of Chartered Accountants of British Columbia (now the Chartered Professional Accountants of British Columbia), and the chair of the Canadian Institute of Chartered Accountants. Terry is currently the president and CEO of PHEMI, an adjunct professor at Simon Fraser University, and a partner with Magellan Angel Partners. Previously he served as the secretary/treasurer and technology adviser for the Michael Smith Foundation for Health and Research, and was one of the entrepreneurs-in-residence at SFU Venture Labs.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.